Literature DB >> 30069443

Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer.

Marios A Diamantopoulos1, Panagiotis Tsiakanikas1, Andreas Scorilas1.   

Abstract

Non-coding RNAs (ncRNAs) constitute a heterogeneous group of RNA molecules in terms of biogenesis, biological function as well as length and structure. These biological molecules have gained attention recently as a potentially crucial layer of tumor cell progression or regulation. ncRNAs are expressed in a broad spectrum of tumors, and they play an important role not only in maintaining but also in promoting cancer development and progression. Recent discoveries have revealed that ncRNAs may act as key signal transduction mediators in tumor signaling pathways by interacting with RNA or proteins. These results reinforce the hypothesis, that ncRNAs constitute therapeutic targets, and point out their clinical potential as stratification markers. The major purpose of this review is to mention the emergence of the importance of ncRNAs, as molecules which are correlated with cancer, and to discuss their clinical implicit as prognostic diagnostic indicators, biomarkers, and therapeutic targets.

Entities:  

Keywords:  Biomarker; long non-coding RNA (lncRNA); small non-coding RNA (sncRNA); transcriptomics

Year:  2018        PMID: 30069443      PMCID: PMC6046292          DOI: 10.21037/atm.2018.06.10

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  210 in total

Review 1.  Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.

Authors:  Richard S Geary; Daniel Norris; Rosie Yu; C Frank Bennett
Journal:  Adv Drug Deliv Rev       Date:  2015-02-07       Impact factor: 15.470

Review 2.  Transcriptome analysis using next-generation sequencing.

Authors:  Kai-Oliver Mutz; Alexandra Heilkenbrinker; Maren Lönne; Johanna-Gabriela Walter; Frank Stahl
Journal:  Curr Opin Biotechnol       Date:  2012-09-25       Impact factor: 9.740

3.  The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia.

Authors:  J Dürig; U Dührsen; L Klein-Hitpass; J Worm; J B Rode Hansen; H Ørum; M Wissenbach
Journal:  Leukemia       Date:  2011-03-01       Impact factor: 11.528

4.  Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.

Authors:  Haiyang Guo; Musaddeque Ahmed; Fan Zhang; Cindy Q Yao; SiDe Li; Yi Liang; Junjie Hua; Fraser Soares; Yifei Sun; Jens Langstein; Yuchen Li; Christine Poon; Swneke D Bailey; Kinjal Desai; Teng Fei; Qiyuan Li; Dorota H Sendorek; Michael Fraser; John R Prensner; Trevor J Pugh; Mark Pomerantz; Robert G Bristow; Mathieu Lupien; Felix Y Feng; Paul C Boutros; Matthew L Freedman; Martin J Walsh; Housheng Hansen He
Journal:  Nat Genet       Date:  2016-08-15       Impact factor: 38.330

5.  A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition.

Authors:  Manuel Beltran; Isabel Puig; Cristina Peña; José Miguel García; Ana Belén Alvarez; Raúl Peña; Félix Bonilla; Antonio García de Herreros
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

6.  The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Authors:  Jaroslaw Jendrzejewski; Huiling He; Hanna S Radomska; Wei Li; Jerneja Tomsic; Sandya Liyanarachchi; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

7.  Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.

Authors:  Sotirios G Papageorgiou; Christos K Kontos; Panagiotis Tsiakanikas; Georgia Stavroulaki; Anthi Bouchla; Diamantina Vasilatou; Efthymia Bazani; Afroditi Lazarakou; Andreas Scorilas; Vasiliki Pappa
Journal:  Leuk Res       Date:  2018-04-26       Impact factor: 3.156

8.  The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.

Authors:  Marissa Iden; Samantha Fye; Keguo Li; Tamjid Chowdhury; Ramani Ramchandran; Janet S Rader
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

9.  Association between SNPs in Long Non-coding RNAs and the Risk of Female Breast Cancer in a Chinese Population.

Authors:  Tao Xu; Xiu-Xiu Hu; Xiang-Xiang Liu; Han-Jin Wang; Kang Lin; Yu-Qin Pan; Hui-Ling Sun; Hong-Xin Peng; Xiao-Xiang Chen; Shu-Kui Wang; Bang-Shun He
Journal:  J Cancer       Date:  2017-04-09       Impact factor: 4.207

10.  The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients.

Authors:  M Avgeris; K Stravodimos; E G Fragoulis; A Scorilas
Journal:  Br J Cancer       Date:  2013-05-23       Impact factor: 7.640

View more
  35 in total

1.  Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis.

Authors:  Chen Fang; Le Xu; Wei He; Jun Dai; Fukang Sun
Journal:  Cell Cycle       Date:  2019-10-15       Impact factor: 4.534

2.  miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.

Authors:  Maria-Alexandra Papadimitriou; Aristea-Maria Papanota; Panagiotis G Adamopoulos; Katerina-Marina Pilala; Christine-Ivy Liacos; Panagiotis Malandrakis; Nefeli Mavrianou-Koutsoukou; Dimitrios Patseas; Evangelos Eleutherakis-Papaiakovou; Maria Gavriatopoulou; Efstathios Kastritis; Margaritis Avgeris; Meletios-Athanasios Dimopoulos; Evangelos Terpos; Andreas Scorilas
Journal:  Br J Cancer       Date:  2021-10-30       Impact factor: 7.640

3.  Integrated SMRT and Illumina Sequencing Provide New Insights into Crocin Biosynthesis of Gardenia jasminoides.

Authors:  Tengfei Shen; Yongjie Zheng; Qian Liu; Caihui Chen; Lili Huang; Shaoyong Deng; Meng Xu; Chunxia Yang
Journal:  Int J Mol Sci       Date:  2022-06-05       Impact factor: 6.208

Review 4.  Tumor Suppressive Effects of GAS5 in Cancer Cells.

Authors:  Jesminder Kaur; Nur'ain Salehen; Anwar Norazit; Amirah Abdul Rahman; Nor Azian Abdul Murad; Nik Mohd Afizan Nik Abd Rahman; Kamariah Ibrahim
Journal:  Noncoding RNA       Date:  2022-05-28

Review 5.  Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients.

Authors:  Anastasios Gkountakos; Pietro Delfino; Rita T Lawlor; Aldo Scarpa; Vincenzo Corbo; Emilio Bria
Journal:  Ther Adv Med Oncol       Date:  2021-05-25       Impact factor: 8.168

6.  Lantern: an integrative repository of functional annotations for lncRNAs in the human genome.

Authors:  Swapna Vidhur Daulatabad; Rajneesh Srivastava; Sarath Chandra Janga
Journal:  BMC Bioinformatics       Date:  2021-05-26       Impact factor: 3.169

7.  Rising Roles of Small Noncoding RNAs in Cotranscriptional Regulation: In Silico Study of miRNA and piRNA Regulatory Network in Humans.

Authors:  Massimiliano Chetta; Lorena Di Pietro; Nenad Bukvic; Wanda Lattanzi
Journal:  Genes (Basel)       Date:  2020-04-29       Impact factor: 4.096

Review 8.  Beyond MicroRNAs: Emerging Role of Other Non-Coding RNAs in HPV-Driven Cancers.

Authors:  Mariateresa Casarotto; Giuseppe Fanetti; Roberto Guerrieri; Elisa Palazzari; Valentina Lupato; Agostino Steffan; Jerry Polesel; Paolo Boscolo-Rizzo; Elisabetta Fratta
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

9.  Do lncRNAs and circRNAs expression profiles influence discoid lupus erythematosus progression?-a comprehensive analysis.

Authors:  Jing Xuan; Yaoyang Xiong; Linjun Shi; Beatrice Aramini; Haiyan Wang
Journal:  Ann Transl Med       Date:  2019-12

10.  LncRNA HOTAIR promotes proliferation and inhibits apoptosis by sponging miR-214-3p in HPV16 positive cervical cancer cells.

Authors:  Yu Zhou; Yuqing Wang; Mingying Lin; Daiqian Wu; Min Zhao
Journal:  Cancer Cell Int       Date:  2021-07-28       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.